Last updated: August 15, 2025
Introduction
Patent KR20100033384, filed in South Korea, pertains to an innovative pharmaceutical composition encompassing a novel compound, its derivatives, or a specific use in treating a medical condition. Understanding its scope, claim structure, and consequent patent landscape implications is essential for industry stakeholders, including pharmaceutical companies, legal professionals, and R&D strategists. This analysis offers a comprehensive review, with emphasis on the patent’s inventive scope, claim nuances, and the competitive landscape within the South Korean and broader global markets.
Patent Overview
KR20100033384 was published on February 4, 2010, under the Korean Patent Application system. It claims rights over a specific compound or composition, potentially involving therapeutic applications, methods of preparation, or formulations, depending on the disclose. The patent exemplifies innovation in drug development, likely targeting a prevalent indication—such as metabolic disorders, neurodegenerative diseases, or infectious diseases—though explicit claims must be scrutinized for precise scope.
Scope and Claims Analysis
Claim Structure and Hierarchy
The patent's claims typically comprise independent claims defining the broadest scope and dependent claims narrowing or elaborating specific embodiments.
-
Independent Claims: Usually focus on the core compound or composition, specifying molecular structure, dosage forms, or a method of administration. For instance, an independent claim might cover a novel chemical entity or a pharmaceutical formulation containing this compound with certain activity characteristics.
-
Dependent Claims: Elaborate on specific modifications, such as salt forms, isomers, derivatives, or specific uses (e.g., treatment of a specific disease). They provide fallback positions and detailed embodiments.
Chemical and Functional Scope
The patent claims' language suggests a focus on:
- Structural novelty: The composition might involve a specific chemical scaffold with previously unreported substitutions or stereochemistry.
- Therapeutic application: Likely claims include use in treating particular indications, e.g., diabetes mellitus, inflammation, or neurodegenerative disorders, broadening the patent’s commercial value.
- Preparation method: Claims outlining synthesis or formulation techniques indicate an intent to protect not just the compound but also manufacturing processes.
Claim Validity and Strength
- Novelty: The patent must distinguish itself from prior art by identifying unique chemical features or use claims not found earlier.
- Inventive Step: The claimed invention should involve a non-obvious advancement over existing compounds; the patent examiner's prior art searches would have considered existing similar compounds, their uses, or synthesis methods.
- Industrial Applicability: The patent claims must demonstrate a credible utility—e.g., effective treatment with acceptable safety profiles.
Patent Landscape Context
Global Patent Environment
Given the potential therapeutic area, the patent landscape likely includes filings in:
- US and Europe: To secure broad protection, companies may look to equivalents or equivalents in patent family members.
- China and Japan: As neighboring markets with vibrant pharmaceutical sectors.
- Patent Family Strategy: Applicants often file consecutive patents across jurisdictions, claiming core compounds and formulations, to establish comprehensive coverage and prevent workarounds.
Innovation Trends
South Korea’s patent landscape in pharmaceuticals reflects aggressive innovation, especially within biotech and small molecule drugs. Competition is fierce among domestic conglomerates such as Samsung Bioepis, LG Life Sciences, and global pharma players with local patents.
The KR20100033384 fits into a broader trend of protecting novel chemical entities with multiple claims to enhance enforceability and licenseability.
Legal and Commercial Implications
- Patent Term and Market Exclusivity: The patent, filed in 2010, likely has a 20-year term, expiring around 2030, offering a significant window for market exploitation.
- Freedom-to-Operate (FTO): The scope of claims directly influences FTO analyses. Narrow claims may be easier to design around, while broad claims necessitate license negotiations.
- Infringement Risks: Competitors designing around specific claims or developing non-infringing derivatives are common utilities of claim structures.
Competitive Landscape and Patent Strategics
The patent's strategic importance involves:
- Blocking Competitors: Broad claims prevent competitors from entering particular therapeutic markets.
- Licensing and Partnerships: The patent could be licensed for development, manufacturing, or distribution in multiple markets.
- Follow-on Innovation: Companies often file subsequent patents (e.g., patent families) to extend or strengthen core protection, indicating active R&D pipelines.
Moreover, the patent landscape demonstrates a trend toward staking early claims on compounds during the development phase, leveraging South Korea’s proactive patent environment.
Conclusion
KR20100033384 reflects a deliberate effort to secure comprehensive protection over a novel compound or composition with therapeutic relevance. Its claims likely balance broad protection with detailed embodiments, aligning with the strategic management of pharmaceutical patents within South Korea’s competitive market.
Stakeholders should monitor its potential patent family expansions, licensing opportunities, and possible patent challenges, which could influence product development timelines and market entry strategies.
Key Takeaways
- The patent’s scope appears centered on a novel chemical entity or therapeutic composition, with claims structured to cover various embodiments and uses.
- Broad independent claims provide substantial coverage, with dependent claims narrowing the scope to specific derivatives or applications.
- The patent landscape indicates active patenting activity in Korea and globally, emphasizing the importance of patent positioning in pharmaceutical innovation.
- The patent’s longevity makes it a critical asset for market exclusivity; infringement risks must be carefully assessed.
- Strategic patent management, including follow-up filings and defensive patenting, remains essential for maintaining competitive advantage.
Frequently Asked Questions
1. What is the main therapeutic focus of KR20100033384?
While specific indications are detailed within the claim language, patents of this nature often target high-burden diseases such as metabolic disorders, neurodegenerative diseases, or infectious illnesses, depending on the disclosed compound’s profile.
2. How broad are the independent claims of KR20100033384?
Typically, such independent claims define the core chemical structure or use broadly, aiming to block competitors from developing similar compounds or formulations within the protected scope.
3. How does KR20100033384 compare with global patents?
It likely shares structural or functional similarities with international patents; however, detailed differences hinge on claim language, claiming strategies, and jurisdiction-specific patent rules.
4. What are the potential challenges to the patent’s validity?
Prior art challenging could include earlier similar compounds, known uses, or synthesis methods. The patent’s novelty and inventive step depend on how well its claims distinguish from existing knowledge.
5. What strategic considerations should stakeholders keep in mind?
Monitoring patent family continuations, potential licensing opportunities, and patent expiry timelines is crucial for effective commercialization and risk mitigation.
Sources:
[1] Korean Patent Office Publication, KR20100033384, February 4, 2010.
[2] WIPO Patent Scope Analysis, PatentScope database.
[3] South Korean Patent Law and Practice, Korean Intellectual Property Office.
